Logo

CNP

CenterPoint Energy, Inc.

CNP

CenterPoint Energy, Inc. • NYSE
$39.98 ▲ 0.08% (+0.03)
Market Cap $26.10 B
52w High $40.50
52w Low $30.59
Dividend Yield 0.88%
P/E 25.3
Volume 1.37M
Outstanding Shares 652.87M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $1.961B ▲ $525M ▲ $252M ▲ 12.851% ▲ $0.45 ▲ $889M ▲
Q2-2025 $1.944B ▼ $510M ▼ $198M ▼ 10.185% ▲ $0.3 ▼ $818M ▼
Q1-2025 $2.92B ▲ $517M ▲ $297M ▲ 10.171% ▼ $0.45 ▲ $979M ▲
Q4-2024 $2.262B ▲ $493M ▲ $248M ▲ 10.964% ▲ $0 ▼ $858M ▲
Q3-2024 $1.856B $459M $193M 10.399% $0.3 $774M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $646M ▼ $45.049B ▲ $34.014B ▲ $11.035B ▲
Q2-2025 $776M ▼ $44.099B ▼ $33.08B ▼ $11.019B ▲
Q1-2025 $1.894B ▲ $44.486B ▲ $33.531B ▲ $10.955B ▲
Q4-2024 $585M ▼ $43.768B ▲ $33.102B ▲ $10.666B ▲
Q3-2024 $643M $42.893B $32.358B $10.535B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $293M ▲ $742M ▲ $-1.261B ▼ $465M ▲ $-54M ▲ $-480M ▲
Q2-2025 $198M ▼ $560M ▲ $-1.107B ▼ $-613M ▼ $-1.16B ▼ $-569M ▲
Q1-2025 $297M ▲ $410M ▼ $-234M ▲ $1.053B ▲ $1.229B ▲ $-628M ▲
Q4-2024 $248M ▲ $889M ▲ $-1.93B ▼ $942M ▲ $-99M ▼ $-1.123B ▼
Q3-2024 $193M $136M $-959M $870M $47M $-708M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Electric Transmission Distribution
Electric Transmission Distribution
 $1.09Bn ▲$1.07Bn ▼$1.19Bn ▲$1.36Bn ▲
Natural Gas Segment
Natural Gas Segment
 $1.17Bn ▲$1.88Bn ▲$760.00M ▼$620.00M ▼

Five-Year Company Overview

Income Statement

Income Statement CenterPoint’s revenue has been relatively steady in recent years after a period of earlier growth, which is typical for a regulated utility with limited pricing flexibility. Margins have generally improved, with operating profit trending upward as the company gains efficiency and benefits from a growing asset base. Net income, however, has been uneven: profits rebounded strongly after a loss earlier in the period, then eased off and have only recently ticked back up. Overall, the earnings profile looks solid but not perfectly smooth, reflecting one‑off items, regulatory outcomes, and weather impacts that can move results around year to year.

Balance Sheet

Balance Sheet The balance sheet shows a business that has been expanding its asset base steadily, driven by heavy investment in infrastructure and grid modernization. Equity has grown, but debt has grown faster, meaning the company is more leveraged today than at the start of the period. This is common for utilities, but it does increase sensitivity to interest rates and regulatory decisions about cost recovery. Cash on hand is very limited, so liquidity depends heavily on access to capital markets and credit facilities rather than large cash reserves.

Cash Flow

Cash Flow Operating cash flow has been positive overall but somewhat inconsistent from year to year, which can reflect timing of fuel costs, regulatory recoveries, and working capital swings. Free cash flow has been clearly negative throughout the period, mainly because CenterPoint is spending heavily on capital projects like grid upgrades and system expansion. This pattern is typical for a growth‑oriented utility, but it means the company relies on external financing—debt and equity—to fund much of its investment program. The key question over time will be how well these investments translate into stable, regulated earnings and cash flows that comfortably cover interest, dividends, and ongoing capex.

Competitive Edge

Competitive Edge CenterPoint operates with a strong regulated utility footprint, effectively holding monopoly‑like positions in many of its service territories. Regulation gives it predictable allowed returns on its investments, creating a stable, long‑term revenue base, though it also caps upside and introduces regulatory risk. The company benefits from large scale across electric and gas operations, which can help spread fixed costs and support efficiency. Its presence in high‑growth regions, especially parts of Texas, is an additional advantage, as customer and load growth can support continued expansion of its rate base over time.

Innovation and R&D

Innovation and R&D CenterPoint is leaning into technology and infrastructure upgrades rather than traditional lab‑style R&D. It is rolling out smart meters, advanced grid controls, and AI‑driven predictive analytics to improve reliability and response during storms, aiming to build one of the most resilient coastal grids in the country. On the gas side, it is using advanced leak‑detection tools to find and fix methane emissions more quickly, which supports both safety and environmental goals. The company is also integrating more renewable energy, supporting electric vehicle infrastructure, and planning a very large, multi‑year capital program focused on grid modernization and cleaner energy, which, if executed well, could strengthen its long‑term position.

Summary

CenterPoint looks like a classic, capital‑intensive regulated utility that is in the middle of a major investment cycle. Earnings and operating profit have generally trended upward, though net income has been somewhat lumpy, reflecting the realities of regulation, weather, and one‑off factors. The balance sheet shows rising leverage as the company funds large grid and gas system upgrades, making regulatory support and capital market access especially important. Its competitive moat is strong, rooted in regulated monopoly territories and scale, while its focus on smart grids, renewables integration, and resilience investments suggests a business that is trying to stay ahead of the energy transition rather than simply maintain the status quo. The main trade‑offs to watch are between growth investments and financial flexibility, and between stable regulated returns and the evolving demands of regulators and customers around reliability and decarbonization.

NEWS

November 25, 2025 · 6:15 PM UTC

Ascendis Announces Extension of FDA Review Period for TransCon CNP (navepegritide) for Children with Achondroplasia

Read more

November 17, 2025 · 4:01 PM UTC

Results of Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) in Children with Achondroplasia Published in JAMA Pediatrics

Read more

October 23, 2025 · 6:25 AM UTC

CenterPoint Energy reports strong Q3 2025 results; reiterates 2025 and 2026 full year guidance

Read more

October 21, 2025 · 6:30 AM UTC

CenterPoint Energy announces sale of its Ohio Natural Gas Business to National Fuel Gas Company for $2.62 billion

Read more

October 8, 2025 · 4:01 PM UTC

Ascendis Submits Marketing Authorisation Application to the European Medicines Agency for TransCon® CNP for Treatment of Children with Achondroplasia

Read more